News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XenoPort, Inc. (XNPT) Announces Presentations at the American Academy of Neurology



3/18/2013 8:05:19 AM

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present the following posters at the 65th Annual Meeting of the American Academy of Neurology in San Diego, California:

AP (arbaclofen placarbil)
Spasticity

• An Ongoing Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity Due to Multiple Sclerosis Session Info: Poster Session P03: March 19, 2:00 pm - 6:30 pm PT Poster #: P03.267

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES